Ejnmmi Research

OCT 13, 2026 · JOURNAL ARTICLE

Detecting pathological response to neoadjuvant therapy in rectal cancer by [18F]-FDG and [18F]-FAPI-42 PET/MRI

Ejnmmi Research

Accurate preoperative assessment of pathological response to neoadjuvant therapy (NAT) in rectal cancer remains challenging, particularly after immunotherapy. This study aimed to e

OCT 13, 2026 · JOURNAL ARTICLE

Targeting EGFR and HER2 in bladder cancer: receptor profiling and therapeutic potential of 213bismuth alpha-particle therapy

Ejnmmi Research

Bladder cancer is a major global health burden, with non-muscle-invasive bladder cancer (NMIBC) accounting for the majority of cases. Current standard-of-care therapy with BCG fail

AUG 18, 2026 · JOURNAL ARTICLE

Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy

Ejnmmi Research

Small prospective intraindividual comparison showing [99mTc]Tc-PSMA-GCK01 SPECT/CT has comparable biodistribution to [68Ga]PSMA-11 PET/CT for lesion phenotyping in mCRPC, but limited by sample size (n=10) and single centre, requiring larger validation before clinical implementation.